This study examined levels of three glia‐derived biomarkers, TREM2, YKL‐40 and chitotriosidase, in the CSF of people with genetic FTD due to mutations in GRN, C9orf72, and MAPT. Here, CHIT1 is linked to frontotemporal dementia.